Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Bio-Rad Laboratories (BIO) Non-Current Deffered Revenue (2016)

Bio-Rad Laboratories has reported Non-Current Deffered Revenue over the past 2 years, most recently at $4.4 million for Q3 2016.

Quarterly Non-Current Deffered Revenue changed N/A to $4.4 million in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Sep 2016, changed N/A year-over-year, with the annual reading at $3.7 million for FY2015, N/A changed from the prior year.
Non-Current Deffered Revenue was $4.4 million for Q3 2016 at Bio-Rad Laboratories, up from $3.7 million in the prior quarter.
Over five years, Non-Current Deffered Revenue peaked at $4.4 million in Q3 2016 and troughed at $3.7 million in Q4 2015.